ConductScience.org, home

Paper35938677

Platelets and tyrosine kinase inhibitors: clinical features, mechanisms of action, and effects on physiology.

Zheng TJ and 7 others. Am J Physiol Cell Physiol, 2022. Cited by 22 papers, by iCite.

Cite this record

ConductScience Library. Platelets and tyrosine kinase inhibitors: clinical features, mechanisms of action, and effects on physiology. Papers, record 35938677. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35938677

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Platelets and tyrosine kinase inhibitors: clinical features, mechanisms of action, and effects on physiology.
PubMed
Journal
Am J Physiol Cell Physiol
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
1.85
iCite
Revised in PubMed
2023-10-02
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zheng TJTony Jhttps://orcid.org/0000-0003-3691-1271
2Parra-Izquierdo IIvánhttps://orcid.org/0000-0002-8831-1115
3Reitsma SEStéphanie Ehttps://orcid.org/0000-0002-7058-5038
4Heinrich MCMichael C
5Larson MKMark K
6Shatzel JJJoseph J
7Aslan JEJoseph Ehttps://orcid.org/0000-0002-8873-0387
8McCarty OJTOwen J Thttps://orcid.org/0000-0001-9481-0124

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HemostaticsMajor topic
Platelet ActivationMajor topic
Agammaglobulinaemia Tyrosine Kinase
Blood Platelets
Janus Kinases
Platelet Aggregation
Platelet Glycoprotein GPIIb-IIIa Complex
Protein Kinase Inhibitors
Syk Kinase
Tyrosine
src-Family Kinases

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
F30 HL158079NHLBI NIH HHSUnited StatesF30HL158079PubMed and NIHNIH RePORTER
R01 HL101972NHLBI NIH HHSUnited StatesR01HL101972PubMedNIH RePORTER
R01 HL151367NHLBI NIH HHSUnited StatesR01HL151367PubMed and NIHNIH RePORTER
R01 HL146549NHLBI NIH HHSUnited StatesR01HL146549PubMed and NIHNIH RePORTER
P20 GM103443NIGMS NIH HHSUnited StatesP20GM103443PubMed and NIHNIH RePORTER

Download CSV of grants

References217

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132631841JAK inhibitors in COVID-19: the need for vigilance regarding increased inherent thrombotic risk.Eur Respir J2020https://conductscience.org/library/papers/32631841PubMed
230692122Thrombotic microangiopathy as a cause of cardiovascular toxicity from the BCR-ABL1 tyrosine kinase inhibitor ponatinib.Blood2019https://conductscience.org/library/papers/30692122PubMed
312006504Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.Clin Cancer Res2002https://conductscience.org/library/papers/12006504PubMed
430819914Differences and similarities in the effects of ibrutinib and acalabrutinib on platelet functions.Haematologica2019https://conductscience.org/library/papers/30819914PubMed
524779514Discovery of GS-9973, a selective and orally efficacious inhibitor of spleen tyrosine kinase.J Med Chem2014https://conductscience.org/library/papers/24779514PubMed
621058007Platelet receptor signaling in thrombus formation.J Mol Med (Berl)2011https://conductscience.org/library/papers/21058007PubMed
730030853The effect of Bruton's tyrosine kinase (BTK) inhibitors on collagen-induced platelet aggregation, BTK, and tyrosine kinase expressed in hepatocellular carcinoma (TEC).Eur J Haematol2018https://conductscience.org/library/papers/30030853PubMed
825900780Human platelet IgG Fc receptor FcγRIIA in immunity and thrombosis.J Thromb Haemost2015https://conductscience.org/library/papers/25900780PubMed
934130349Tyrosine Kinase Inhibitor Sunitinib Delays Platelet-Induced Coagulation: Additive Effects of Aspirin.Thromb Haemost2022https://conductscience.org/library/papers/34130349PubMed
1030685871Optimizing Platelet GPVI Inhibition versus Haemostatic Impairment by the Btk Inhibitors Ibrutinib, Acalabrutinib, ONO/GS-4059, BGB-3111 and Evobrutinib.Thromb Haemost2019https://conductscience.org/library/papers/30685871PubMed
1116002463Role of tyrosine kinase inhibitors in cancer therapy.J Pharmacol Exp Ther2005https://conductscience.org/library/papers/16002463PubMed
1234839996Review of the development of BTK inhibitors in overcoming the clinical limitations of ibrutinib.Eur J Med Chem2022https://conductscience.org/library/papers/34839996PubMed
1310506151The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors.J Biol Chem1999https://conductscience.org/library/papers/10506151PubMed
1420189992An important role of the SRC family kinase Lyn in stimulating platelet granule secretion.J Biol Chem2010https://conductscience.org/library/papers/20189992PubMed
1517158345Activation of platelet function through G protein-coupled receptors.Circ Res2006https://conductscience.org/library/papers/17158345PubMed
1626371140Tyrosine Kinase Inhibitor-Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia.J Clin Oncol2015https://conductscience.org/library/papers/26371140PubMed
1710704823Tyrosine phosphorylation and association of FcgammaRII and p72(Syk) are not limited to the FcgammaRII signalling pathway.Cell Signal2000https://conductscience.org/library/papers/10704823PubMed
1829269020TCR Signaling: Mechanisms of Initiation and Propagation.Trends Biochem Sci2018https://conductscience.org/library/papers/29269020PubMed
1922201778FES/FER kinase signaling in hematopoietic cells and leukemias.Front Biosci (Landmark Ed)2012https://conductscience.org/library/papers/22201778PubMed
2033537526Protease-activated receptors: An illustrated review.Res Pract Thromb Haemost2021https://conductscience.org/library/papers/33537526PubMed

See all 217 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
42619595Monovalent Anti-FcγRIIA Antibody Blocks Immune-Mediated Thrombocytopenia and Thrombosis With Minimal Adverse Side Effects in Mice.Arterioscler Thromb Vasc Biol2026https://conductscience.org/library/papers/42619595PubMed
42181826Stent thrombosis associated with non-response to clopidogrel despite co-administration of aspirin and ibrutinib.Eur Heart J Case Rep2026https://conductscience.org/library/papers/42181826PubMed
42148361Development Trends of Janus Kinase Inhibitors (JAKi) Over Three Decades: From Common to Rare Diseases.Drug Des Devel Ther2026https://conductscience.org/library/papers/42148361PubMed
41896928Proteomic remodeling during tumor cell-induced platelet aggregation unveils metastatic drivers in colorectal cancer.Cancer Cell Int2026https://conductscience.org/library/papers/41896928PubMed
41458387Spleen and Bruton's tyrosine kinase inhibitors for the management of adult immune thrombocytopenia: A systematic review and meta-analysis of randomized controlled trials.Clin Hematol Int2025https://conductscience.org/library/papers/41458387PubMed
41142963An overview of advanced nanocarrier systems for Ibrutinib delivery: overcoming pharmacokinetic barriers and enabling targeted cancer therapy.Int J Pharm X2025https://conductscience.org/library/papers/41142963PubMed
40952587Tyrosine kinase inhibitors - balancing the haemostatic scales: a review of associated thrombosis and bleeding.J Thromb Thrombolysis2026https://conductscience.org/library/papers/40952587PubMed
40886252Structure-guided discovery of a novel BTK inhibitor inducing apoptosis and G1 phase arrest in tumor cells.Mol Divers2026https://conductscience.org/library/papers/40886252PubMed
40728654JAM-A: Adhesion Receptor and Signaling Regulator in Atherosclerosis.Curr Atheroscler Rep2025https://conductscience.org/library/papers/40728654PubMed
40532792Current and future landscape of Bruton tyrosine kinase inhibitors in allergy.J Allergy Clin Immunol2025https://conductscience.org/library/papers/40532792PubMed
39893011Pharmacological effects of small molecule BCR-ABL tyrosine kinase inhibitors on platelet function.J Pharmacol Exp Ther2025https://conductscience.org/library/papers/39893011PubMed
39374578Unbiased high-throughput screening of drug-repurposing libraries identifies small-molecule inhibitors of clot retraction.Blood Adv2025https://conductscience.org/library/papers/39374578PubMed
38994958TGF-β-Based Therapies for Treating Ocular Surface Disorders.Cells2024https://conductscience.org/library/papers/38994958PubMed
36858794Fibrin reaches out to GPVI to influence how platelets shape clots.J Thromb Haemost2023https://conductscience.org/library/papers/36858794PubMed
36219587Effect of antiplatelet agents and tyrosine kinase inhibitors on oxLDL-mediated procoagulant platelet activity.Blood Adv2023https://conductscience.org/library/papers/36219587PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BTK695PubTator's text mininghttps://conductscience.org/library/genes/695NCBI Gene
SYK6850PubTator's text mininghttps://conductscience.org/library/genes/6850NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35938677

GET https://conductscience.org/api/papers/v1/35938677/references?page=2